mortality/aging
• increase in the proportion of moribund mice following indomethacin induced small bowel enteritis
|
digestive/alimentary system
N |
• intestinal morphology is similar to wild-type controls in nonstressed mice and in mice treated with dextran sulfate
|
• significant reductions in the proportions of Firmicutes and Actinobacteria and a significant increase in Bacteroidetes and Clostridiales in the feces
|
• sustained h[Gly2]-GLP-2 (glucagon like peptide 2) administration fails to elicit an intestinotrophic response unlike in wild-type controls
|
• increase in small intestinal sensitivity to indomethacin or irinotecan toxicity
• increased small bowel bacterial load
|
• expression analysis indicates defects in Paneth cell regulated host-bacteria interactions and cultured Paneth cells show reduced bactericidal activity after stimulation with carbamylcholine and LPS
|
homeostasis/metabolism
• increase in the proportion of moribund mice following indomethacin induced small bowel enteritis
|
• more mice show signs of bacterial infection after indomethacin treatment
• irinotecan treatment induces a significant decrease in jejunal crypt density and depth in contrast to controls where only crypt depth is decreased
• systemic bacteremia is seen after irinotecan treatment
|